D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 45.34 CNY -1.82% Market Closed
Market Cap: 18.8B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note
Dizal Jiangsu Pharmaceutical Co Ltd
/
Balance Sheet
/
Total Current Liabilities

Dizal Jiangsu Pharmaceutical Co Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dizal Jiangsu Pharmaceutical Co Ltd
Total Current Liabilities Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Total Current Liabilities
¥448.4m
CAGR 3-Years
63%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Current Liabilities
¥12.8B
CAGR 3-Years
22%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Current Liabilities
¥2.7B
CAGR 3-Years
48%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Total Current Liabilities
¥1.6B
CAGR 3-Years
27%
CAGR 5-Years
41%
CAGR 10-Years
32%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Current Liabilities
¥22.7B
CAGR 3-Years
32%
CAGR 5-Years
39%
CAGR 10-Years
68%
Imeik Technology Development Co Ltd
SZSE:300896
Total Current Liabilities
¥297.7m
CAGR 3-Years
49%
CAGR 5-Years
46%
CAGR 10-Years
N/A

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Total Current Liabilities?
Total Current Liabilities
448.4m CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Total Current Liabilities amounts to 448.4m CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
36%

Over the last year, the Total Current Liabilities growth was 80%. The average annual Total Current Liabilities growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been 63% over the past three years , 36% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 198,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.